Current Issue

November 2014

Duodenoscopes transmitted E. coli
Contaminated duodenoscopes triggered a 2013 outbreak of a rare strain of Escherichia coli infections at a single hospital in northeastern Illinois, according to a report published online Oct. 7 in JAMA.

FDA approves combination pill for hepatitis C
The first combination pill to treat chronic hepatitis C virus genotype 1 infection was approved by the Food and Drug Administration Oct. 10.

Timing of first gluten doesn’t matter
The timing of introducing gluten into babies’ diets doesn’t alter their risk for developing celiac  disease later, according to two separate reports published online Oct. 1 in the New England Journal of Medicine.

Specialty drugs: High cost, but high value
Although a number of highly specialized medications are entering practice with increasingly higher price tags and additional costs beyond administration, evidence suggests that it is worthwhile for the overall health care system to cover them.

Industry payments to doctors, hospitals top $4.5 billion
The drug and device industry made about $4.6 billion in payments to physicians and teaching hospitals in the last 5 months of 2013, according to updated data from the government.

PDF | Interactive Version